Edit My Profile

Integrated Search Menu

Gary Marchant

Profile photo
Sandra Day O'Connor College of Law
Professor of Law
Faculty, DTPHX Campus, Mailcode 9520
Sandra Day O'Connor College of Law
Exec Dir & Regent's Professor
Faculty w/Admin Appointment, TEMPE Campus, Mailcode 9520
School for the Future of Innovation in Society > Related Faculty
Faculty, DTPHX Campus, Mailcode 9520
Lincoln Center Applied Ethics
Lincoln Professor of Law, Ethics & Emerging Technologies
Faculty, Tempe Campus, Mailcode 9520
School of Life Sciences
Regents' Professor; Lincoln Professor of Emerging Technologies, Law & Ethics
Faculty, Tempe Campus, Mailcode 9520
Biography

Regents' Professor of Law
Professor of Law
Faculty Director and Faculty Fellow, Center for Law, Science & Innovation
Lincoln Professor of Emerging Technologies, Law and Ethics
Senior Sustainability Scientist, Global Institute of Sustainability, ASU

Gary Marchant’s research interests include legal aspects of genomics and personalized medicine, the use of genetic information in environmental regulation, risk and the precautionary principle, and governance of emerging technologies such as nanotechnology, neuroscience, biotechnology and artificial intelligence. He teaches courses in Law, Science & Technology, Genetics and the Law, Biotechnology: Science, Law and Policy, Health Technologies and Innovation, Privacy, Big Data and Emerging Technologies, and Artificial Intelligence: Law and Ethics.  He was named a Regents' Professor in 2011 and also is a professor in ASU’s School of Life Sciences, is a Distinguished Sustainability Scientist in ASU’s Global Institute of Sustainability, and is a Lincoln Center for Applied Ethics Professor.

Prior to joining the College faculty in 1999, Professor Marchant was a partner at the Washington, D.C., office of Kirkland & Ellis, where his practice focused on environmental and administrative law. During law school, he was Editor-in-Chief of theHarvard Journal of Law & Technology and editor of the Harvard Environmental Law Review, and was awarded the Fay Diploma (awarded to top graduating student at Harvard Law School).

Professor Marchant frequently lectures about the intersection of law and science at national and international conferences. He has authored more than 150 articles and book chapters on various issues relating to emerging technologies. Among other activities, he has served on five National Academy of Sciences committees, has been the principal investigator on several major grants, and has organized numerous academic conferences on law and science issues.

CV
Binary Data Curriculum Vitae
Education

B.Sc., University of British Columbia (1980)

Ph.D., Genetics, University of British Columbia (1986)

M.P.P., Kennedy School of Government, Harvard University (1990)

J.D., Harvard Law School (1990)

Research Interests

Gary E. Marchant , Kenneth W. Abbott , Braden Allenby, Innovative Governance Models for Emerging Technologies (Edward Elgar Publishing, 2013).
K487.T4 I5 2013

The Growing Gap Between Emerging Technologies and Legal-ethical Oversight: The Pacing Problem (Gary Marchant, Braden Allenby, & Joseph Herkert, eds., Springer 2011).
T174.5 .G76 2011

‘Soft Law' Mechanisms for Nanotechnology: Liability and Insurance Drivers, 17 J. Risk Research 709 (2014).
T174.5 .J67 Online

Complexity and Anticipatory Socio-Behavioral Assessment of Government Attempts to Induce Clean Technologies, 61 UCLA L. Rev. 1858 (2013-2014).
K25 Online

Gregory N. Mandel & Gary E. Marchant, The Living Regulatory Challenges of Synthetic Biology, 100 Iowa L. Rev. 155 (2014).
K9 .O88 Online

Kenneth W. Abbott & Gary E. Marchant, International Harmonization of Nanotechnology Governance Through "Soft Law" Approaches, 9 Nanotechnology L. & Bus. 393 (2013).
K14 .A5685 Online

Rachel A. Lindor & Gary E. Marchant, Personalized Medicine and Genetic Malpractice, 15 Genetics in Med. 921 (2013).
RB155 Online

The Case Against Mandatory Labeling of GM Food, 28 Natural Res. & Env't 11 (2013).
K14 .A7371

Publications
  • Mossman, Kenneth L. Genetic susceptibility and radiological health and safety. Genomics and Environmental Regulation: Science, Ethics and Law (2008).
  • Sharp, Richard, Marchant, Gary E, Grodsky, Jamie. Genomics and Environmental Regulation: Ethical, Legal and Policy Issues. (2007).
  • Gary Marchant. Genetic Data in Toxic Tort Litigation. J. Law & Policy (2006).
  • Gary Marchant, Douglas Sylvester. Transnational Models for Regulation of Nanotechnology. J. Law, Medicine & Ethics (2006).
  • Marchant, Gary E (Author) . Applications of Biomarkers in Forensics and Toxic Tort Proceedings. Toxicological Biomarkers (2006).
  • Marchant, Gary E. Law, Science & Technology. Encyclopedia of Science, technology, and Ethics (2005).
  • Gary Marchant. Property Rights and Benefit-Sharing for DNA Donors?. Jurimetrics (2005).
  • . . Encyclopedia of Science, Technology, and Ethics (2005).
  • Cary Coglianese, Gary Marchant. Shifting Sands: The Limits of Science in Setting Risk Standards. Penn. L. Rev (2004).
  • Cary Coglianese, Gary Marchant. The EPA's Risky Reasoning. Regulation (2004).
  • Marchant, Gary E, Mossman, Kenneth L. Arbitrary & Capricious: The Precautionary Principle in the European Union Courts. (2004).
  • . . Environmentalism and the Technologies of Tomorrow (2004).
  • Gary Marchant. From General Policy to Legal Rule: The Aspirations and Limitations of the Precautionary Principle. Envtl. Health Perspect (2003).
  • Gary Marchant. Genomics and Toxic Substances: Part I - Toxicogenomics. Envtl. Law Rep (2003).
  • Gary Marchant. Genomics and Toxic Substances: Part II - Toxicogenetics. Envtl. Law Rep (2003).
  • Gary Marchant. Introduction: Confidence-Building Measures for Genetically Modified Foods. Jurimetrics (2003).
  • Gary Marchant, Andrew Askland. GM Foods: Potential Public Consultation and Participation Mechanisms. Jurimetrics (2003).
  • . . Review of: Precaution, Environmental Science, and Preventive Public Policy (2003).
  • Carol Henry, Gary Marchant. Use of Genomics in Toxicology and Epidemiology: Findings and Recommendations of a Workshop. Envtl. Health Perspect (2002).
  • Gary Marchant. A Synthetic Vitreous Fiber (SVF) Occupational Exposure Database: Implementing the SVF Health and Safety Partnership Program. Applied Occupational and Environmental Hygiene (2002).
  • Gary Marchant. Biotechnology and the Precautionary Principle: Right Question, Wrong Answer. Int. J. Biotechnology (2002).
  • Gary Marchant. Legal Criteria and Judicial Precedents Relevant to Incorporation of Hormesis into Regulatory Decision-Making. The Science of the Total Environment (2002).
  • Gary Marchant. The Genome Cometh. Chemistry Business (2002).
  • Gary Marchant. Toxicogenomics and Toxic Torts. Trends in Biotech (2002).
  • Kenneth Mossman, Gary Marchant. The Precautionary Principle and Radiation Protection. Risk: Health, Safety & Environment (2002).
  • Edward Calabrese, Gary Marchant. Editorial: Recognizing and Incorporating Health Benefits of Pollutants in Risk Assessment. Human & Ecol. Risk Assess (2001).
  • Gary Marchant. A Regulatory Precedent for Hormesis. Human & Experimental Toxicology (2001).
  • Gary Marchant. Genetics and Toxic Torts. Seton Hall L. Rev (2001).
  • Gary Marchant. The Precautionary Principle: An 'Unprincipled' Approach to Biotechnology Regulation. J. of Risk Research (2001).
  • . . Review of: Human Germline Gene Therapy: Scientific, Moral and Political Issues (2001).
  • Gary Marchant. Genetic Susceptibility And Biomarkers in Toxic Injury Litigation. Jurimetrics (2000).
  • Michael Baram, Ellen Flannery, Patricia Davis, Gary Marchant. Regulatory and Liability Considerations. Boston U. J. Sci. & Tech. L (2000).
Research Activity
Summer 2017
Course NumberCourse Title
LAW 781Independent Study
Spring 2017
Course NumberCourse Title
HON 494Special Topics
LAW 599Thesis
LAW 617Genetics and the Law
BIO 691Seminar
LAW 791Seminar
BIO 791Seminar
Fall 2016
Course NumberCourse Title
HON 494Special Topics
BIO 591Seminar
LAW 691Seminar
BIO 691Seminar
LAW 703Law, Science, and Technology
LAW 781Independent Study
LAW 791Seminar
Summer 2016
Course NumberCourse Title
LAW 781Independent Study
Spring 2016
Course NumberCourse Title
HON 494Special Topics
LAW 599Thesis
LAW 617Genetics and the Law
LAW 781Independent Study
LAW 791Seminar
Fall 2015
Course NumberCourse Title
HON 494Special Topics
BIO 691Seminar
LAW 691Seminar
LAW 703Law, Science, and Technology
LAW 781Independent Study
LAW 791Seminar
Summer 2015
Course NumberCourse Title
LAW 781Independent Study
Spring 2015
Course NumberCourse Title
HON 494Special Topics
MAS 590Reading and Conference
LAW 599Thesis
LAW 703Law, Science, and Technology
LAW 781Independent Study
LAW 791Seminar
Fall 2014
Course NumberCourse Title
HON 494Special Topics
LAW 617Genetics and the Law
BMD 617Genetics and the Law
LAW 691Seminar
BIO 691Seminar
LAW 781Independent Study
LAW 791Seminar
Summer 2014
Course NumberCourse Title
LAW 781Independent Study
Spring 2014
Course NumberCourse Title
HON 494Special Topics
BIO 591Seminar
LAW 599Thesis
LAW 607Nanotechnology
LAW 703Law, Science, and Technology
LAW 781Independent Study
LAW 791Seminar
Fall 2013
Course NumberCourse Title
HON 494Special Topics
BIO 591Seminar
BIO 598Special Topics
LAW 599Thesis
LAW 617Genetics and the Law
LAW 781Independent Study
LAW 791Seminar
Summer 2013
Course NumberCourse Title
LAW 781Independent Study
Spring 2013
Course NumberCourse Title
HON 494Special Topics
BIO 591Seminar
LAW 691Seminar
LAW 703Law, Science, and Technology
LAW 781Independent Study
LAW 791Seminar
Fall 2012
Course NumberCourse Title
HON 494Special Topics
BIO 591Seminar
BIO 598Special Topics
LAW 607Nanotechnology
LAW 617Genetics and the Law
LAW 791Seminar
Presentations
  • Marchant, Gary. Nanotechnology Regulation: The United States Approach. Conference on New Global Regulatory Frontiers: Evaluating What Will Work for Nanotechnology. Monash University, Melbourne, Australia (Jul 2006).
  • Marchant, Gary. Legal Pressures and Incentives for Personalized Medicine. Beyond Genome 2006 Conference, San Francisco, CA (Jun 2006).
  • Marchant, Gary. Legal, Ethical and Policy Issues with Pharmacogenomics. TGEN, Phoenix, AZ (Apr 2006).
  • Marchant, Gary. Pros and Cons of Cost-Benefit Analysis; Issues in Implementing Cost-Benefit Analysis; and The Precautionary Principle: An Alternative to Cost-Benefit Analysis?. Institute on Science in the Courts, George Mason University Law & Economics Center, Tucson, AZ (Apr 2006).
  • Marchant, Gary. The Intersection of Law & Science. State Bar of Arizona CLE on Scientific Evidence, Phoenix, AZ (Apr 2006).
  • Marchant, Gary. Regulatory and Legal Implications of Hormesis. Society of Toxicology Annual Meeting, San Diego, CA (Mar 2006).
  • Marchant, Gary. Aspirations and Limitations of the Precautionary Principle. Society of Toxicology Annual Meeting, San Diego, CA (Mar 2006).
  • Marchant, Gary. Incorporating Genetic Susceptibility Data in Standard-Setting for Air Pollutants. Society of Toxicology Annual Meeting, San Diego, CA (Mar 2006).
  • Marchant, Gary. Genetics and Criminal Responsibility. ASU Adventures in Learning Lecture Series, Scottsdale, AZ (Feb 2006).
  • Marchant, Gary. Global Positioning Systems (GPS), Privacy and the Law. Conference on Surveillance Technologies, Privacy and the Law, ASU College of Law, Tempe, AZ (Feb 2006).
  • Marchant, Gary. Evolution, Creation, and the Law. MetaNexus Board Presentation, Tempe, AZ (Jan 2006).
  • Marchant, Gary. The Problems with the Precautionary Principle. Washington Health Legislative Conference, Seattle, WA (Dec 2005).
  • Marchant, Gary. The Precautionary Principle in the European Union Courts. Institute for Economic Affairs, London, UK (Oct 2005).
  • Marchant, Gary. Arbitrary and Capricious: The Precautionary Principle in European and Global Lawmaking. Centre for the New Europe, Brussels, Belgium (Oct 2005).
  • Marchant, Gary. Genetically Based Toxic Tort Suits. 9th International Conference on Environmental Mutagens, San Francisco, CA (Sep 2005).
  • Marchant, Gary. Genetics and Toxic Torts. Sciences for Judges V, Brooklyn Law School, New York, NY (Apr 2005).
  • Marchant, Gary. Toxic Torts: How Genetics Can Shape the Debate Regarding Proximate cause and Damages. National Association of Women Judges Genome Justice Pilot Project, Phoenix (Apr 2005).
  • Marchant, Gary. Transnational Models for Regulating Nanotechnology. Conference on Nanoethics, University of South Carolina, Columbia SC (Mar 2005).
  • Marchant, Gary. Labeling of GM Foods - A "No Brainer" .... Or Not?. Western Regional Bioethics Conference, Tempe, AZ (Feb 2005).
  • Marchant, Gary. Risk Analysis: As Others See Us, Plenary Session Respondent. Society for Risk Analysis Annual Conference, Palm Springs, CA (Dec 2004).
  • Marchant, Gary. Incorporating Genomics into Risk Assessment and Regulation. Society for Risk Analysis Annual Conference, Palm Springs, CA (Dec 2004).
  • Marchant, Gary. Transnational Regulatory Models for Molecular Nanotechnology. 1st Conference on Advanced Technology, Foresight Institute, Arlington, VA (Oct 2004).
  • Marchant, Gary. Legal and Ethical Issues of Genomics. Spirit of the Senses Lecture, Barrow Neurological Institute, Phoenix, AZ (Sep 2004).
  • Marchant, Gary. Genetic Testing: How Will It Impact Your Life in the Next Five Years?. Gathering for the Great Minds Awesome Hearts Lecture series, Interfaith Community Care, Sun City West, AZ (Sep 2004).
  • Marchant, Gary. Genomics and Environmental Regulation. National Human Genome Research Institute ELSI Genetic Variation Consortium, Rockville, MD (Jul 2004).
  • Marchant, Gary. Regulatory Incentives and Impediments to Fuel-Celled Vehicles. Conference on Legal Issues in Developing Hydrogen Technologies, George Washington University Law School, Washington, D.C (Jun 2004).
  • Marchant, Gary. Regulatory Applications and Acceptance of Hormesis. American Industrial Hygiene Conference, Expo 2004, Atlanta, Ga (May 2004).
  • Marchant, Gary. Property Interests of Genetic Research Donors?. Conference on Human Genetic Sampling: Ethical, Legal, and Social Considerations, ASU College of Law, Tempe, AZ (Mar 2004).
  • Marchant, Gary. An Occupational Exposure Database for Synthetic Vitreous Fibers (SVFs). Society of Toxicology Annual Meeting, Baltimore, MD (Mar 2004).
  • Marchant, Gary. The Precautionary Principle. Capstone course: Issues in Biotechnology, Arizona State University School of Life Sciences, Tempe, AZ (Mar 2004).
  • Marchant, Gary. Contagion, Risk and Fear: Lessons From SARS, Mad Cow Disease, West Nile Virus and Anthrax. ASU President's Community Enrichment Program, Scottsdale, AZ (Feb 2004).
  • Marchant, Gary. Genetics and the Law: An Introduction. Arizona Federal District Court Conference, Phoenix, AZ (Feb 2004).
  • Marchant, Gary. Toxicogenomics: Ethical, Legal and Social Issues. National Institute of Environmental Health Sciences (NIEHS), Division of Extramural Research and Training (DERT), Science Retreat, Southern Pines, NC (Dec 2003).
  • Marchant, Gary. Risk in the Republic. Greater Phoenix Humanists Association, Tempe, AZ (Oct 2003).
  • Marchant, Gary. Risk in the Republic. World Presidents Association, Phoenix, AZ (Oct 2003).
  • Marchant, Gary. Genetic Susceptibility and Environmental Exposures. Special Committee on Bioethics, ABA Annual Meeting, San Francisco, CA (Aug 2003).
  • Marchant, Gary. How Genomics Will Change Environmental Regulation. EPA Region 10, Seattle, WA (Jul 2003).
  • Marchant, Gary. Hopes and Hypes of the Biomedical Revolution: Genetic Testing. 9th Circuit Judicial Conference, Kaua'i, Hawaii (Jun 2003).
  • Marchant, Gary. Human Cloning. What Every Lawyer Should Know About Bioethics Law, conference, Arizona State Bar, Phoenix, AZ (Apr 2003).
  • Marchant, Gary. The Human Genome and Beyond. State Capital Global Law Firm Group 2003 MidwinterMeeting, Scottsdale, AZ (Mar 2003).
  • Marchant, Gary. Ethical and Legal Dilemmas of Genetic Testing. Greater Phoenix Humanist Association (Mar 2003).
  • Marchant, Gary. Genetics and Toxic Torts. conference on Issues in Biotechnology and Genetics, co-sponsored by Eccles Institute of Human Genetics and FREE, Salt Lake City, UT (Mar 2003).
  • Marchant, Gary. Genomics and Environmental Regulation. ABA Section of Environment Annual Meeting, Keystone, CO (Mar 2003).
  • Marchant, Gary. Genetic Susceptibility: Regulatory Issues. Annual Meeting of the Society for Risk Analysis, New Orleans (Dec 2002).
  • Marchant, Gary. Potential Public Consultation and Participation Mechanisms. Conference on Confidence Building Measures for Genetically Modified Foods, ASU College of Law, Tempe, AZ (Dec 2002).
  • Marchant, Gary. Genetics and Toxic Torts. Maricopa County Superior Court Judicial Education Day, Phoenix, AZ (Nov 2002).
  • Marchant, Gary. Genomics and the Law. National Academy of Science's conference entitled "Toxicogenemics: The 'New Biology' Revolution in Environmental Health Sciences," Washington, D.C (Nov 2002).
  • Marchant, Gary. Ethical and Legal Dilemmas of Genetic Testing. ASU President's Community Enrichment Program, Scottsdale, AZ (Oct 2002).
  • Marchant, Gary. Non-Linear Dose Response: Legal Standards for the Admission of Novel Scientific Theories in Regulatory Decision-Making. International Conference on Non-Linear Dose-Response Relationships in Biology, Toxicology and Medicine, University of Massachusetts, Amherst (Jun 2002).
  • Marchant, Gary. The Role of the Federal Government in Environmental Regulation. State Bar of Arizona Environmental and Natural Resources Law Section Conference, Who Are Your Environmental Regulators?, Phoenix, AZ (May 2002).
  • Marchant, Gary. Genetic Biomarkers in Civil Litigation. American Bar Association Section of Litigation Annual Meeting, Boston, MA (Apr 2002).
  • Marchant, Gary. Biotechnology and Public Confidence: Legal & Policy Issues. Arizona Bioindustry Cluster, Phoenix, AZ (Apr 2002).
  • Marchant, Gary. Ten Ways Genomics Could Change Environmental Regulation. Environmental Law Institute, Washington, D.C (Mar 2002).
  • Marchant, Gary. Ten Ways Genomics Could Change Environmental Regulation. Seton Hall Law School Faculty Colloquium (Mar 2002).
  • Marchant, Gary. Ten Ways Genomics Could Change Environmental Regulation. Wilson Center, Washington, D.C (Mar 2002).
  • Marchant, Gary. Risk in the Republic: The Struggle to Define a Rational Risk Policy. ASU's President's Community Enrichments Programs (Feb 2002).
  • Marchant, Gary. Some Legal Implications of the Beryllium Lymphocyte Proliferation Test (BLPT). Beryllium Lymphocyte Proliferation Test Panel, Menlo Park, CA (Feb 2002).
  • Marchant, Gary. Frankenfoods or Better Foods? The GM Foods Controversy. ASU College of Law Alumni, Yuma, AZ (Jan 2002).
  • Marchant, Gary. Legal Implications of Toxicogenomics for Environmental Regulation and Toxic Torts. National Institutes of Health/National Institute of Environmental Health Sciences, Symposium on Gene Expression and Proteomics in Environmental Health Research, Bethesda, MD (Dec 2001).
  • Marchant, Gary. Legal Aspects of Genetic Testing, Capstone Course in Biotechnology. Arizona State University (Nov 2001).
  • Marchant, Gary. Bioterrorism: The Threat and Legal Consequences. Arizona State University College of Law (Nov 2001).
  • Marchant, Gary. Risk in the Republic. Motorola Science Advisory Board, Mesa, Az (Sep 2001).
  • Marchant, Gary. Economics and Environmental Policy. Economics 591, ASU (Jun 2001).
  • Marchant, Gary. Genetic Biomarkers and Tort Litigation. National Institute of Environmental Health Sciences, Research Triangle Park, N.C (May 2001).
  • Marchant, Gary. Risk Is a Four-Letter Word. Law Society Dinner Arizona State University College of Law, Tempe, Az (May 2001).
  • Marchant, Gary. The Precautionary Principle. Goldwater Institute,Phoenix, AZ (May 2001).
  • Marchant, Gary. Legal Criteria, Obstacles and Precedents for Considering Hormesis in Regulation, Issues and Applications in Toxicology and Risk Assessment. Conference sponsored by the U.S. Environmental Protection Agency, et al., Dayton, Ohio (Apr 2001).
  • Marchant, Gary. Risk, Uncertainty and the Precautionary Principle. University of Colorado School of Law, Faculty Colloquium, Boulder, Co (Apr 2001).
  • Marchant, Gary. Genetic Biomarkers and Toxic Torts. American Bar Association, Appellate Judges Seminar, Phoenix, AZ (Mar 2001).
  • Marchant, Gary. Genetic Biomarkers and Toxic Torts. American Association of Law Schools Annual Meeting, Session on "Genetics and the Courtroom," San Francisco, Ca (Jan 2001).
  • Marchant, Gary. The Precautionary Principle: The Wrong Answer to the Right Question. International Conference on Biotechnology in the Global Economy: Science and the Precautionary Principle, Kennedy School of Government, Harvard University (Sep 2000).
  • Marchant, Gary. Biotech Materials and Medical Devices in the New Millennium. The Third Annual Technology Symposium, Boston University School of Law (Feb 2000).
Service
  • Society for Risk Analysis Section on Risk Science and the Law, Chair (2005 - Present)
  • Nonlinearity in Biology, Toxicology and Medicine (CRC Press), Associate Editor (2003 - Present)
  • National Research Council (National Academy of Sciences) Committee on Applications of Toxicogenomic Technologies to Predictive Technologies, Member (2005 - 2006)
  • National Research Council (National Academy of Sciences) Committee on State Practices in Setting Mobile Source Emission Standards, Member (2004 - 2006)
  • State Bar of Arizona, Executive Council of Environmental & Natural Resources Law Section, Elected Member (2004 - 2006)
  • Harvard Environmental Law Review, Editor (Present)
  • Harvard Journal of Law & Technology, Editor-in-Chief (Present)
  • Harvard Law & Technology Society, Vice-President (Present)
  • Translational Genomics Research Institute (TGEN), Conflicts of Interest Committee, Member (Present)
Expertise Areas
BioScience
Genomics
Environmental/Sustainability Law
Genetics
Health Law
Technology Law
Traumatic Brain Inury
Bioethics and Science Policy
Law
Neuroscience
Science Policy
Nanotechnology
Biotechnology
Resilience
Risk
Technology and Society